tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of David Risinger, 131 are a BUY (51.37%), 105 are a HOLD (41.18%), 19 are a SELL (7.45%).
Analyst David Risinger, currently employed at LEERINK, carries an average stock price target met ratio of 76.44% that have a potential upside of 20.55% achieved within 312 days.
David Risinger’s has documented 510 price targets and ratings displayed on 32 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on VRTX, Vertex Pharmaceuticals at 29-Dec-2025.
Analyst best performing recommendations are on BHC (BAUSCH HEALTH COMPANIES).
The best stock recommendation documented was for ALKS (ALKERMES PLC) at 1/21/2016. The price target of $35 was fulfilled within 1 day with a profit of $1.31 (3.89%) receiving and performance score of 38.88.
Average potential price target upside
Analyst name
Rating
Rating initiation date
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
Since 24-Jan-2022
$269
$40.51 (17.73%)
$250
27 days ago
(12-Dec-2025)
17/19 (89.47%)
$45.02 (20.10%)
467
Buy
Since 17-May-2024
$280
$51.51 (22.54%)
$200
1 months 26 days ago
(13-Nov-2025)
5/6 (83.33%)
$46.77 (20.05%)
236
Buy
Since 31-Oct-2023
$237
$8.51 (3.72%)
$188
2 months 4 days ago
(04-Nov-2025)
2/3 (66.67%)
$18.96 (8.70%)
109
Hold
Since 14-May-2025
$235
$6.51 (2.85%)
$251
2 months 5 days ago
(03-Nov-2025)
16/17 (94.12%)
$16.96 (7.78%)
282
Buy
Since 16-Oct-2020
$260
$31.51 (13.79%)
$235
2 months 5 days ago
(03-Nov-2025)
14/15 (93.33%)
$41.96 (19.24%)
483
Which stock is David Risinger is most bullish on?
Which stock is David Risinger is most reserved on?
What Year was the first public recommendation made by David Risinger?
